Cell and Tissue Banking

, 6:255

Preventing disease transmission by deceased tissue donors by testing blood for viral nucleic acid

  • D. Michael Strong
  • Karen Nelson
  • Marge Pierce
  • Susan L. Stramer

DOI: 10.1007/s10561-005-2834-4

Cite this article as:
Strong, D.M., Nelson, K., Pierce, M. et al. Cell Tissue Banking (2005) 6: 255. doi:10.1007/s10561-005-2834-4


Nucleic acid testing (NAT) has reduced the risk of transmitting infectious disease through blood transfusion. Currently NAT for HIV-1 and HCV are FDA licensed and performed by nearly all blood collection facilities, but HBV NAT is performed under an investigational study protocol. Residual risk estimates indicate that NAT could potentially reduce disease transmission through transplanted tissue. However, tissue donor samples obtained post-mortem have the potential to produce an invalid NAT result due to inhibition of amplification reactions by hemolysis and other factors. The studies reported here summarize the development of protocols to allow NAT of deceased donor samples with reduced rates of invalid results. Using these protocols, inventories from two tissue centers were tested with greater than 99% of samples producing a valid test result.


Deceased tissue donorsInfectious diseaseNATNucleic acid testingTissue transplantation



hepatitis B virus


hepatitis C virus


human immunodeficiency virus


internal control


investigational new drug study protocol approved by the Food and Drug Administration


Nucleic acid testing


polymerase chain reaction


transcription-mediated amplification

Copyright information

© Springer 2005

Authors and Affiliations

  • D. Michael Strong
    • 1
  • Karen Nelson
    • 1
  • Marge Pierce
    • 2
  • Susan L. Stramer
    • 3
  1. 1.Puget Sound Blood Center/Northwest Tissue Center
  2. 2.American Red CrossSt. Paul
  3. 3.American Red CrossGaithersburg